Hologic Announces Pricing Of Financing In Connection With Acquisition Of Gen-Probe

Hologic, Inc. HOLX announced today the pricing of its private placement of $1.0 billion in aggregate principal amount of its 6.25% Senior Notes due 2020. The offering is expected to close concurrently with the completion of Hologic's acquisition of Gen-Probe Incorporated GPRO. The acquisition is subject to the satisfaction of certain customary closing conditions, including obtaining the approval of Gen-Probe's stockholders. Gen-Probe has scheduled a Special Meeting of Stockholders for July 31, 2012 to vote on the pending acquisition and Hologic expects to close the acquisition on or about August 1, 2012. Separately, Hologic announced that it has received expected pricing on its anticipated $2.80 billion of Senior Secured Credit Facilities to be obtained in connection with its acquisition of Gen-Probe. Those facilities are anticipated to comprise of the following: $300 million revolving credit facility, initially at LIBOR plus 3.00%, due 2017; $1.0 billion tranche A term loan facility, initially at LIBOR plus 3.00%, due 2017; and $1.50 billion tranche B term loan facility, at LIBOR plus 3.50%, with a LIBOR floor of 1.00%, due 2019.